Skip to main content
Click Here to Register
Agenda
August Agenda
New York Agenda
Faculty
August Faculty
New York Faculty
Keyword Search
Toggle navigation
Login
Home
Click Here to Register
Agenda
August Agenda
New York Agenda
Faculty
August Faculty
New York Faculty
Keyword Search
Full Schedule
Home
Full Schedule
All Days
Thu, Sep 28
Fri, Sep 29
Sat, Sep 30
Full Schedule
16 results found
Type here to filter the list
Saturday, September 30, 2023
8:00 AM – 8:15 AM
ET
Welcome
Co-Chair:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
Co-Chair:
David H. Ilson, MD, PhD
– Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
8:15 AM – 8:50 AM
ET
Session 17: Updates from Recent Meetings
Presenter:
Jordan D. Berlin, MD
– Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
8:50 AM – 9:00 AM
ET
Live Q&A
Moderator:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
Moderator:
David H. Ilson, MD, PhD
– Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist:
Jordan D. Berlin, MD
– Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
9:00 AM – 9:35 AM
ET
Session 18: Novel Newer and Emerging Treatment Options for the Management of Non-MSI-H Metastatic Colorectal Cancer
Presenter:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
9:35 AM – 9:45 AM
ET
Live Q&A
Moderator:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
Moderator:
David H. Ilson, MD, PhD
– Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
9:45 AM – 9:50 AM
ET
Break
9:50 AM – 10:50 AM
ET
Non-CME Innovation Theater (Sponsored By Taiho Oncology)
10:50 AM – 11:20 AM
ET
Exhibit Hall
11:20 AM – 11:35 AM
ET
Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - FOLFIRINOX
Presenter:
Jordan D. Berlin, MD
– Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
11:35 AM – 11:50 AM
ET
Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - NALIRIFOX
Presenter:
Milind M. Javle, MD
– MD Anderson Cancer Center, The University of Texas
11:50 AM – 12:05 PM
ET
Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - Discussion
Moderator:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
Moderator:
David H. Ilson, MD, PhD
– Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist:
Jordan D. Berlin, MD
– Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist:
Milind M. Javle, MD
– MD Anderson Cancer Center, The University of Texas
12:05 PM – 12:35 PM
ET
Lunch
12:35 PM – 1:10 PM
ET
Session 20: Significance of Cancer Genetics
Presenter:
Sonia Kupfer, MD
– University of Chicago
1:10 PM – 1:20 PM
ET
Live Q&A
Moderator:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
Moderator:
David H. Ilson, MD, PhD
– Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist:
Sonia Kupfer, MD
– University of Chicago
1:20 PM – 1:55 PM
ET
Session 21: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and Gastric
Presenter:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
1:55 PM – 2:05 PM
ET
Live Q&A
Moderator:
David H. Ilson, MD, PhD
– Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Presenter:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
Back to Top